http://www.bccancer.bc.ca/about/news-stories/stories/personalized-onco-genomics-(pog)-q-a WebDr. Laskin is the co-founder and clinical leader of the Personalized OncoGenomics (POG) program, a translational research effort that uses in-depth genomic sequencing to guide chemotherapy decision-making in a clinically relevant time-frame. For an up-to-date list of publications by Dr. Laskin, please see ResearchGate.
Personalized Onco-Genomics - BC Cancer Foundation
Web15. aug 2024 · Design: Prior to PROFYLE, 3 programs (Personalized Oncogenomics Project (POG), SickKids Cancer Sequencing Program (KiCS), and Personalized Targeted Therapy in Refractory or Relapsed Cancer in Childhood (TRICEPS)) constituted the bulk of childhood precision oncology efforts in Canada. Web× Close. The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. rainbow ohrringe
Altered Gene Expression along the Glycolysis–Cholesterol …
WebJan 2010 - Present13 years 4 months. Vancouver, British Columbia, Canada. When my favourite Uncle was diagnosed with cancer 12 years ago, my eyes were opened to the harsh reality of our cancer ... Webgenomic analysis in the future in an attempt to provide patients with a personalized treatment plan that maximizes ecacy and reduces toxicity. This paper gives a brief history … Personalized onco-genomics (POG) is the field of oncology and genomics that is focused on using whole genome analysis to make personalized clinical treatment decisions. The program was devised at British Columbia's BC Cancer Agency and is currently being led by Marco Marra and Janessa Laskin. … Zobraziť viac The novel approach of comparing a patient's tumour versus normal tissue was first identified in 2010 when assessing the genetic evolution of adenocarcinomas of tongue before and after treatment was received. This … Zobraziť viac Whole Genome Analysis With the advent of next-generation sequencing, the genome-wide sequencing analyses have been made more accessible to thoroughly understand the genetics of each patient's cancer. Genetic material from tumour … Zobraziť viac There are multiple challenges that are preventing the adoption of POGs. The largest challenge is the identification of genetic factors that are promoting cancer growth. These “drivers” need to be understood before any actions can be taken against … Zobraziť viac Genomic and transcriptomic sequence datasets from the 2024 Nature publication encompassing the first 570 "POG" patients have been deposited at the European Genome-phenome Archive Zobraziť viac OMICS technologies are high-throughput methods that help evaluate and unbiased investigate characteristics of the genome, epigenome, transcriptome, proteome, and metabolome. Zobraziť viac Treatment options for aggressive metastatic cancer typically have a poor response rate to conventional treatments. Through this novel approach, analysis of oncogenic factors is undertaken to identify the unique molecular signatures of the individual's … Zobraziť viac rainbow official site clothing store